title: NSAIDs and developmental toxicity.
authors.affiliation: Pfizer Global Research & Development, Drug Safety Evaluation, Groton, Connecticut 06340, USA. melissa_s_tassinari@groton.pfizer.com
authors.forename: Melissa S
authors.initials: MS
authors.lastname: Tassinari
authors.forename: Jon C
authors.initials: JC
authors.lastname: Cook
authors.forename: Mark E
authors.initials: ME
authors.lastname: Hurtt
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000328:Adult; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000633:toxicity*; D051545:Cyclooxygenase 1; D016861:Cyclooxygenase Inhibitors / Q000633:toxicity; D005260:Female; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors; D008565:Membrane Proteins; D011247:Pregnancy; D011451:Prostaglandin-Endoperoxide Synthases; D011817:Rabbits; D051381:Rats; D013723:Teratogens / Q000633:toxicity*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D008565:Membrane Proteins; D013723:Teratogens; D051545:Cyclooxygenase 1; C496511:PTGS1 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; C496513:Ptgs1 protein, rat